Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Sponsor offers 'psilocybin light' advisory approach as alternate to broad licensing bill

House Committee on Health, Human Services and Elderly Affairs · January 14, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Representative Buzz Schaer presented HB1809 as a regulatory‑light alternative that sets up an advisory council to study therapeutic psilocybin policy and solicit national expert input; he said the council could be used to inform a careful, evidence‑based approach and that he would accept amendments to narrow the bill to advisory functions.

Representative Buzz Schaer described HB1809 as a more cautious, advisory‑focused alternative to broader licensing proposals for therapeutic psilocybin. The bill establishes a temporary advisory council charged with reviewing national regulatory models, soliciting input from leading researchers and administrators in other states, and producing…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans